Increased intestinal VEGF expression and mucosal vascularization in patients with spondylarthropathy by Hindryckx, Pieter et al.
INCREASED INTESTINAL VEGF EXPRESSION AND MUCOSAL 
VASCULARIZATION IN PATIENTS WITH SPONDYLARTHROPATHY. 
 
P. Hindryckx (1), G. Serry (1), D. Laukens (1), H. Peeters (1), M. De Vos (1) / [1] Gent 
 
BACKGROUND: Chronic intestinal inflammation observed in about a quarter of patients 
with spondylarthropathy (SpA) is linked to Crohn’s disease (CD).  Increased expression of 
Vascular Endothelial Growth Factor (VEGF) and intestinal mucosal angiogenesis has been 
described in Crohn’s disease, in correlation with disease activity. 
STUDY AIM: To investigate VEGF expression and mucosal angiogenesis in SpA patients 
with or without subclinical gut inflammation. 
METHODS: Sections of paraffin-embedded ileal and colonic biopsies from healthy controls 
(HC) (negative control, number of biopsies (N)=20),  Crohn patients (positive control, N=20), 
SpA patients without gut inflammation (N=30) and SpA patients with subclinical gut 
inflammation (N=28) were immunostained for VEGF and for CD31 and blindly scored by 
computerized morphometric analysis using specialized software. 
RESULTS: Both intestinal VEGF activity and mucosal vascular density (MVD) were higher 
in SpA patients versus healthy controls, independent of the presence of chronic gut 
inflammation (HC vs SpA patients without gut inflammation: P<0,05 and P<0,01 respectively 
for VEGF and MVD; HC vs SpA patients with chronic gut inflammation: P<0,001 both for 
VEGF and MVD).   Nevertheless, presence of subclinical chronic gut inflammation was 
associated with much stronger intestinal VEGF expression and mucosal vascularization, 
resembling the pattern of Crohn’s disease (SpA patients with gut inflammation vs SpA 
patients without gut inflammation: P<0,001 for VEGF; P<0,01 for MVD).  Unlike in Crohn 
patients however, the high VEGF activity and MVD observed in SpA patients with chronic 
gut inflammation was not clearly dependent on the presence of active inflammation in the 
biopsy (epithelial infiltration of polymorphonuclear cells, ulcerations, granulomas). 
CONCLUSION:  A pro-angiogenic intestinal phenotype is observed in SpA patients which, 
unlike in Crohn’s disease, is not clearly dependent of active gut inflammation. 
 
